Canton Strategic Holdings CNTN
NASDAQ CNTN
$2.28 +0.03 (+1.33%)
As of: Sep 4, 2026 · 3:59 PM EDT

Canton Strategic Holdings (CNTN) Change in Accured Expenses (2021 - 2026)

Canton Strategic Holdings' (CNTN) quarterly Change in Accured Expenses came in at -$1.5 million in Q1 2026, down 22752.21% YoY from N/an in Q1 2025, and down 196.73% on a QoQ basis from $1.5 million in Q4 2025.

Analysis

Canton Strategic Holdings (CNTN) Change in Accured Expenses (2021 - 2026) Analysis & Trends

Canton Strategic Holdings (CNTN) has 6 years of Change in Accured Expenses data on file, last reported at -$1.5 million in Q1 2026.

  • Quarterly Change in Accured Expenses fell 22752.21% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$378695.0 (down 147.91% YoY) and the FY2025 annual result came in at $1.1 million, up 156.55% from the prior year.
  • Change in Accured Expenses fell to -$1.5 million in Q1 2026, from $1.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.5 million in Q4 2025 to a low of -$1.5 million in Q1 2026.
  • A 5-year average of $36530.7 and a median of -$6376.0 in 2025 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 6658.29% — and 2026, when it tumbled 22752.21%.
  • Tracing CNTN's Change in Accured Expenses over 5 years: stood at $10597.0 in 2022, then soared by 6658.29% to $716176.0 in 2023, then plunged by 106.25% to -$44774.0 in 2024, then surged by 3464.2% to $1.5 million in 2025, then plunged by 196.73% to -$1.5 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$1.5 million (Q1 2026), $1.5 million (Q4 2025), and -$368137.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Canton Strategic Holdings 493.37 Mn 493.37 Mn - 1.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.93 Mn
Mar 31, 2026 -1.46 Mn
Dec 31, 2025 1.51 Mn
Sep 30, 2025 -208,336.00
Jun 30, 2025 -219,588.00
Mar 31, 2025 -6,376.00
Dec 31, 2024 -44,774.00
Sep 30, 2024 789,628.00
Jun 30, 2024 51,935.00
Mar 31, 2024 -378,942.00
Dec 31, 2023 716,176.00
Sep 30, 2023 122,424.00
Jun 30, 2023 -174,351.00
Mar 31, 2023 51,752.00
Dec 31, 2022 10,597.00
Sep 30, 2022 -6,073.00
Jun 30, 2022 -32,941.00
Mar 31, 2022 -99,338.00
Dec 31, 2021 13,362.00
Sep 30, 2021 157,551.00